-
公开(公告)号:US20190247469A1
公开(公告)日:2019-08-15
申请号:US16315132
申请日:2017-07-06
发明人: James McGrath , Paul Manning , Eugene Scavola
IPC分类号: A61K38/38 , A23L33/19 , A23L33/12 , A23L33/125 , A23L33/13 , A23L33/16 , A23L33/155 , A23L33/26 , A23L33/18 , A23L33/00 , A61K38/40 , A61K31/7016 , A61K31/05 , A61K31/202 , A61K31/702 , A61K31/7004 , A61K38/17 , A61K31/201 , A61K31/14 , A61K31/205 , A61K31/685 , A61K31/015 , A61K31/185 , A61K31/375 , A61K31/355 , A61K31/203 , A61K31/455 , A61K31/593 , A61K31/197 , A61K31/122 , A61K31/51 , A61K31/525 , A61K31/519 , A61K31/4188 , A61K31/714 , A61K33/42 , A61K33/00 , A61K33/14 , A61K31/194 , A61K33/04 , A61K33/26 , A61K33/30 , A61K33/34 , A61K33/32 , A61K31/7076 , A61K31/7068 , A61K31/708 , A61K31/7072 , A61K31/718 , A61K31/733 , A61K9/00
CPC分类号: A61K38/38 , A23L33/00 , A23L33/10 , A23L33/115 , A23L33/12 , A23L33/125 , A23L33/13 , A23L33/155 , A23L33/16 , A23L33/17 , A23L33/18 , A23L33/19 , A23L33/26 , A23L33/40 , A23V2002/00 , A61K9/0053 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/14 , A61K31/185 , A61K31/194 , A61K31/197 , A61K31/201 , A61K31/202 , A61K31/203 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K31/714 , A61K31/718 , A61K31/733 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/26 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K38/1709 , A61K38/40 , A23V2200/30 , A23V2200/32 , A23V2200/324 , A23V2200/332
摘要: The present disclosure provides a nutritional formula comprising alpha-lactalbumin enriched whey protein concentrate; beta-casein enriched milk protein; mildly hydrolyzed milk protein; osteopontin; lactoferrin; oleic acid-palmitic acid-oleic acid triglyceride, wherein palmitic acid is at the SN-2 position of the glycerol backbone of the triglyceride; lactose, wherein the lactose is reduced lactose; lutein; docosahexanoic acid; arachidonic acid; galactooligosaccharides; and polydextrose. The provided nutritional formulas may be useful in providing nutrition and/or promoting postnatal development of a subject (e.g., promoting postnatal development of an infant's gastrointestinal functions, nutrient absorption, immune system development, etc.). Also provided are powder forms, reconstituted formulas, kits, methods, and uses that include or involve a nutritional formula described herein.
-
公开(公告)号:US11547744B2
公开(公告)日:2023-01-10
申请号:US16315132
申请日:2017-07-06
发明人: James McGrath , Paul Manning , Eugene Scavola
IPC分类号: A61K38/38 , A23L33/12 , A23L33/26 , A23L33/125 , A23L33/18 , A23L33/19 , A23L33/00 , A23L33/17 , A23L33/10 , A23L33/115 , A23L33/13 , A23L33/16 , A23L33/155 , A61K9/00 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/14 , A61K31/185 , A61K31/194 , A61K31/197 , A61K31/201 , A61K31/202 , A61K31/203 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K31/714 , A61K31/718 , A61K31/733 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/26 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K38/17 , A61K38/40
摘要: The present disclosure provides a nutritional formula comprising alpha-lactalbumin enriched whey protein concentrate; beta-casein enriched milk protein; mildly hydrolyzed milk protein; osteopontin; lactoferrin; oleic acid-palmitic acid-oleic acid triglyceride, wherein palmitic acid is at the SN-2 position of the glycerol backbone of the triglyceride; lactose, wherein the lactose is reduced lactose; lutein; docosahexanoic acid; arachidonic acid; galactooligosaccharides; and polydextrose. The provided nutritional formulas may be useful in providing nutrition and/or promoting postnatal development of a subject (e.g., promoting postnatal development of an infant's gastrointestinal functions, nutrient absorption, immune system development, etc.). Also provided are powder forms, reconstituted formulas, kits, methods, and uses that include or involve a nutritional formula described herein.
-
公开(公告)号:US20230141907A1
公开(公告)日:2023-05-11
申请号:US18063886
申请日:2022-12-09
发明人: James McGrath , Paul Manning , Eugene Scavola
IPC分类号: A61K38/38 , A23L33/18 , A23L33/19 , A23L33/00 , A23L33/17 , A23L33/10 , A23L33/115 , A23L33/12 , A23L33/13 , A23L33/26 , A23L33/16 , A23L33/125 , A23L33/155 , A61K9/00 , A61K31/015 , A61K31/05 , A61K31/122 , A61K31/14 , A61K31/185 , A61K31/194 , A61K31/197 , A61K31/201 , A61K31/202 , A61K31/203 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/4188 , A61K31/455 , A61K31/51 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/7004 , A61K31/7016 , A61K31/702 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61K31/714 , A61K31/718 , A61K31/733 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/26 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K38/17 , A61K38/40
CPC分类号: A61K38/38 , A23L33/00 , A23L33/10 , A23L33/12 , A23L33/13 , A23L33/16 , A23L33/17 , A23L33/18 , A23L33/19 , A23L33/26 , A23L33/40 , A23L33/115 , A23L33/125 , A23L33/155 , A61K9/0053 , A61K31/05 , A61K31/14 , A61K31/015 , A61K31/51 , A61K31/122 , A61K31/185 , A61K31/194 , A61K31/197 , A61K31/201 , A61K31/202 , A61K31/203 , A61K31/205 , A61K31/355 , A61K31/375 , A61K31/455 , A61K31/519 , A61K31/525 , A61K31/593 , A61K31/685 , A61K31/702 , A61K31/708 , A61K31/714 , A61K31/718 , A61K31/733 , A61K31/4188 , A61K31/7004 , A61K31/7016 , A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K33/00 , A61K33/04 , A61K33/14 , A61K33/26 , A61K33/30 , A61K33/32 , A61K33/34 , A61K33/42 , A61K38/40 , A61K38/1709 , A23V2002/00
摘要: The present disclosure provides a nutritional formula comprising alpha-lactalbumin enriched whey protein concentrate; beta-casein enriched milk protein; mildly hydrolyzed milk protein; osteopontin; lactoferrin; oleic acid-palmitic acid-oleic acid triglyceride, wherein palmitic acid is at the SN-2 position of the glycerol backbone of the triglyceride; lactose, wherein the lactose is reduced lactose; lutein; docosahexanoic acid; arachidonic acid; galactooligosaccharides; and polydextrose. The provided nutritional formulas may be useful in providing nutrition and/ or promoting postnatal development of a subject (e.g., promoting postnatal development of an infant’s gastrointestinal functions, nutrient absorption, immune system development, etc.). Also provided are powder forms, reconstituted formulas, kits, methods, and uses that include or involve a nutritional formula described herein.
-
-